Statins and cancer: A case of meta-uncertainty

American Journal of Medicine

Volumn 110, Issue 9, 2001, Pages 738-740

  Guallar, Eliseo ^a   Goodman, Steven N ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PLACEBO; PRAVASTATIN; SIMVASTATIN;

CANCER INCIDENCE; CANCER INHIBITION; CANCER MORTALITY; CANCER RISK; CARCINOGENICITY; CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG EFFECT; DRUG SAFETY; EDITORIAL; HUMAN; HYPERCHOLESTEROLEMIA; LIVER DYSFUNCTION; META ANALYSIS; MYOPATHY; PRIORITY JOURNAL;

ANTILIPEMIC AGENTS; BIAS (EPIDEMIOLOGY); HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; META-ANALYSIS; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS;

EID: 0035876602     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00758-6     Document Type: Editorial

References (19)

1. Current perspectives on statins
2. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
3. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials
4. Risk factor modification: Rationale for management of dyslipidemia
5. Carcinogenicity of lipid-lowering drugs
6. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase
7. Are there potential non-lipid-lowering uses of statins?
8. Do statins cause cancer? A meta-analysis of large randomized clinical trials
9. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
10. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
11. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
12. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
13. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
14. Follow-up study of patients randomized in the Scandinavian Simvastatin Survival Study (4S) of cholesterol lowering
15. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: A nested case-control study
16. Probability at the bedside: The knowing of chances or the chances of knowing?